Codexis, Inc. (CDXS) vs NovaBridge Biosciences (NBP)
- Codexis, Inc. CDXS 1.24 −8.82%
- NovaBridge Biosciences NBP 1.27 −1.55%
Codexis, Inc. and NovaBridge Biosciences are both Biotechnology companies. Codexis, Inc. and NovaBridge Biosciences are of similar size ($149.6M and $148.9M). Codexis, Inc. grew revenue faster over the last twelve months: 35.9% against −91.8%. NovaBridge Biosciences has the higher net margin (0.00% vs −39.6%) and the higher return on invested capital (0.00% vs −151.2%). Across the 18 metrics below, NovaBridge Biosciences leads on 10 and Codexis, Inc. on 8.
Valuation
Profitability
| Metric | CDXS | NBP | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.02% | 31.10% | 65.16% |
| Operating margin | (35.61%) | 0.00% | 0.00% |
| Net margin | (39.55%) | 0.00% | 0.00% |
| Free cash flow margin | (15.66%) | 0.00% | 0.00% |
| Return on equity | (69.36%) | 0.00% | (56.36%) |
| Return on assets | (23.79%) | 0.00% | (48.04%) |
| Return on invested capital | (151.17%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack